Quantcast

Latest Therapies under investigation for multiple sclerosis Stories

2014-02-27 08:29:40

MISSISSAUGA, ON, Feb. 27, 2014 /CNW/ - Genzyme, a Sanofi company, today announced the Canadian availability of (Pr)LEMTRADA(TM) (alemtuzumab) for the management of adult patients with relapsing-remitting multiple sclerosis (RRMS), with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies. LEMTRADA 12 mg has a dosing and administration schedule of two annual treatment courses. The first...

2013-04-10 23:02:54

According to Ironclad Integrity Ltd MS natural treatments have become all the rage lately as these promise effective results, no side-effects and lower health care bills. The company has released via http://www.SclerosisTreatment.com reviews and price analysis for the most popular MS alternative therapies. Denver, Colorado (PRWEB) April 10, 2013 Health organizations estimate there are about 400,000 Multiple Sclerosis patients in the United States today, but that number is certainly higher...

Eye Scans Help Doctors Tell How Fast Multiple Sclerosis Progression Occurs
2012-12-26 11:04:46

Lawrence LeBlond for redOrbit.com - Your Universe Online Patients with debilitating multiple sclerosis may discover just how fast their nervous system disease is progressing with a new quick and easy test. The test, known as an Optical Coherence Tomography (OCT) scan, takes just a few minutes per eye and can be performed at a general practitioner´s surgery. The finding comes from a test of 164 MS patients measuring the thickness of the lining at the back of the eye. The test was...

New Treatment For Multiple Sclerosis Offers Promising Results
2012-11-01 09:25:28

Lawrence LeBlond for redOrbit.com - Your Universe Online A new drug to fight multiple sclerosis (MS) is showing promise as one of the “most effective” treatment options ever produced for the debilitating disease, according to UK researchers. The drug, which is used to ℠reboot´ a person´s immune system, has been shown to be effective in MS patients who have already failed to respond to the first drug with which they were treated, as well as those who have gone...

2012-07-04 01:20:30

The medication fingolimod reduced inflammatory lesion activity and reduced brain volume loss in patients with multiple sclerosis who participated in a two-year placebo-controlled clinical trial and were assessed by magnetic resonance imaging (MRI) measures, according to a report published Online First by Archives of Neurology, a JAMA Network publication. Fingolimod is the first in a new class of drugs called the sphingosine 1-phosphate receptor (S1PR) modulators that was recently approved...

2012-04-18 05:18:26

(Ivanhoe Newswire) -- An oral drug called ONO-4641 is under investigation because it can reduce the number of lesions in people with multiple sclerosis (MS). The study involved 407 people between the ages of 18 and 55 who had relapsing-remitting MS.  They were given placebo randomly of .05mg, .10mg, or .15 mg of ONO-4641 once per day for 26 weeks.  Patients who had two or more relapses in the two years prior to the study, were included, along with those who had one or more...

2012-01-30 06:08:07

(Ivanhoe Newswire)-- Many of us have heard of or know someone with the dreadful disease known as multiple sclerosis. Affecting approximately 400,000 people in the United States and 2.5 million people worldwide, multiple sclerosis is still incurable and has few effective treatments available. Patients affected by multiple sclerosis are hindered on a daily basis by physical ailments, including fatigue, pain, and difficulty with mobility, as well as problems with social functioning and...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related